14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TPIV
Delisted

TapImmune Inc Fund Signals

$8.34
+0 (+0%)
At Close: Oct 26, 2018

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.650 13 days ( 3.47 % )
Last Price $8.34 0 %
High/ Low $8.34 - $8.34 0%
Chg 7 Days N/A $8.34 $8.34
Chg 30 Days -13.75 % $9.67 $8.34
Chg 12 mos 164.76 % $3.15 $8.34
Trend - 3 mos 16.25 % Width: 37.07 %
Trend - 12 mos 105.01 % Width: 150.04 %
Pred. range - 3 mos $8.90 - $12.20 6.76 % - 46.33 %
Pred. range - 12 mos $12.45 - $31.12 49.23 % - 273.15 %
Short MA avg 3 mos Sell Oct 24, 2018 - 3 days
Long MA avg 3 mos Sell Oct 09, 2018 - 14 days
Short/Long MA avg 3 mos Sell Oct 11, 2018 - 12 days
Short MA avg 12 mos Buy Oct 22, 2018 - 5 days
Long MA avg 12 mos Sell Oct 10, 2018 - 13 days
Short/Long MA avg 12 mos Sell Oct 17, 2018 - 8 days
Pivot Short Sell Oct 25, 2018 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About TapImmune Inc

TapImmune, Inc., a clinical-stage immunotherapy company, develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The company, in collaboration with Mayo Foundation for Medical Education and Research, is developing HER2/neu+, a vaccine technology, which has completed Phase I human clinical trials for the treatment of breast cancer; and Folate Receptor Alpha, a peptide epitope, which has completed Phase I clinic... TPIV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT